In the past months, the AOT executive team has changed our strategy to faster access the market. As a leading force AOT will strengthen the new category of contact-free and autonomous laser robots.
We will partner with implant companies and focus on CMF, extremities and knee solutions – although we can laser any bone!
Our unique integration of Robotics, Laser and Navigation is covered by over 13 patent families globally – and we continue to enhance the CARLO platform to bring the unique benefits of laser bone surgery to more and more patients around the globe.
Our product CARLO, the world’s first laser osteotome, has successfully been used in Europe in over 100 maxillo-facial cases so far. In our series D financing roadshow we have great discussions with VCs as well as with strategic partners.